They may do more harm than good.

It's not a one-size-fits-all drug.

In a 12-week randomized trial, replacing refined wheat with wholegrain rye in a calorie-restricted diet did not produce ...

A post‑meal compound found in python blood curbed appetite in lab mice, hinting at future weight loss therapies.

Scientists have discovered a novel metabolite in pythons that quells appetite without causing gastrointestinal side effects ...

Patients with obesity sometimes have leptin resistance, and the "full" feeling does not get through to the brain. The new ...

People who quit taking popular GLP-1 drugs such as Ozempic might their jeopardize heart health, according to a new study.

Lilly’s experimental drug met endpoints for blood-sugar level reduction and weight loss at trial.

Daily weight fluctuations are normal and shouldn't discourage weight loss efforts. The body stores energy as fat and glycogen, with glycogen levels changing more readily. Weighing yourself every few ...

Drug executives say only their GLP-1 drugs are safe for treating obesity and diabetes as they wage a yearlong campaign to ...

Federal regulators on Thursday approved a new higher-dose version of the blockbuster obesity drug Wegovy that may help users ...